Nuvasive Stock Short Ratio
| NUVADelisted Stock | USD 42.35 0.85 1.97% |
NuVasive fundamentals help investors to digest information that contributes to NuVasive's financial success or failures. It also enables traders to predict the movement of NuVasive Stock. The fundamental analysis module provides a way to measure NuVasive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuVasive stock.
NuVasive |
NuVasive Company Short Ratio Analysis
NuVasive's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current NuVasive Short Ratio | 10.29 X |
Most of NuVasive's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuVasive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, NuVasive has a Short Ratio of 10.29 times. This is 163.85% higher than that of the Health Care Equipment & Supplies sector and 172.94% higher than that of the Health Care industry. The short ratio for all United States stocks is 157.25% lower than that of the firm.
NuVasive Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuVasive's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NuVasive could also be used in its relative valuation, which is a method of valuing NuVasive by comparing valuation metrics of similar companies.NuVasive is currently under evaluation in short ratio category among its peers.
NuVasive Fundamentals
| Return On Equity | 0.0331 | |||
| Return On Asset | 0.0242 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 2.91 B | |||
| Shares Outstanding | 52.45 M | |||
| Shares Owned By Insiders | 0.27 % | |||
| Shares Owned By Institutions | 99.73 % | |||
| Number Of Shares Shorted | 5.76 M | |||
| Price To Earning | 51.79 X | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 1.79 X | |||
| Revenue | 1.2 B | |||
| Gross Profit | 865.43 M | |||
| EBITDA | 211.8 M | |||
| Net Income | 40.41 M | |||
| Cash And Equivalents | 225.98 M | |||
| Cash Per Share | 4.34 X | |||
| Total Debt | 1.01 B | |||
| Debt To Equity | 1.22 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 17.02 X | |||
| Cash Flow From Operations | 169.12 M | |||
| Short Ratio | 10.29 X | |||
| Earnings Per Share | 0.53 X | |||
| Price To Earnings To Growth | 4.83 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 3 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 2.22 B | |||
| Retained Earnings | 86.11 M | |||
| Working Capital | 149.16 M | |||
| Current Asset | 702.83 M | |||
| Current Liabilities | 99.62 M | |||
| Z Score | 2.23 | |||
| Net Asset | 2.22 B |
About NuVasive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuVasive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuVasive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuVasive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |